KRONOX LAB SCIENCES
|
KRONOX LAB SCIENCES Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 7.45 | 6.86 | 5.75 | 4.42 | 565.44 |
| CEPS(Rs) | 8.01 | 7.24 | 6.10 | 4.82 | 4.01 |
| DPS(Rs) | 0.50 | 0.50 | 0.50 | - | - |
| Book NAV/Share(Rs) | 31.30 | 24.28 | 17.87 | 12.06 | 1,674.40 |
| Tax Rate(%) | 25.85 | 25.69 | 25.37 | 25.58 | 25.76 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 33.86 | 33.06 | 31.51 | 22.72 | 23.95 |
| EBIT Margin(%) | 36.97 | 34.20 | 31.84 | 23.16 | 22.81 |
| Pre Tax Margin(%) | 36.85 | 34.20 | 31.84 | 23.06 | 22.32 |
| PAT Margin (%) | 27.33 | 25.42 | 23.76 | 17.16 | 16.57 |
| Cash Profit Margin (%) | 29.35 | 26.80 | 25.19 | 18.73 | 19.04 |
| Performance Ratios | |||||
| ROA(%) | 24.53 | 29.61 | 33.54 | 29.73 | 29.03 |
| ROE(%) | 26.82 | 32.56 | 38.45 | 38.55 | 40.58 |
| ROCE(%) | 36.00 | 43.82 | 51.52 | 51.63 | 55.32 |
| Asset Turnover(x) | 0.90 | 1.16 | 1.41 | 1.73 | 1.75 |
| Sales/Fixed Asset(x) | 2.43 | 2.58 | 2.85 | 4.03 | 4.17 |
| Working Capital/Sales(x) | 1.48 | 1.83 | 2.31 | 3.77 | 2.71 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.41 | 0.39 | 0.35 | 0.25 | 0.24 |
| Receivable days | 74.05 | 68.37 | 73.51 | 84.69 | 91.52 |
| Inventory Days | 26.58 | 28.46 | 37.42 | 31.86 | 28.85 |
| Payable days | 54.30 | 50.41 | 56.53 | 64.28 | 69.59 |
| Valuation Parameters | |||||
| PER(x) | 13.09 | 20.96 | - | - | - |
| PCE(x) | 12.19 | 19.88 | - | - | - |
| Price/Book(x) | 3.12 | 5.92 | - | - | - |
| Yield(%) | 0.51 | 0.35 | - | - | - |
| EV/Net Sales(x) | 3.11 | 4.96 | 0.37 | 0.35 | -0.02 |
| EV/Core EBITDA(x) | 7.98 | 13.94 | 1.12 | 1.42 | -0.09 |
| EV/EBIT(x) | 8.42 | 14.50 | 1.17 | 1.52 | -0.10 |
| EV/CE(x) | 2.68 | 5.52 | 0.50 | 0.75 | -0.05 |
| M Cap / Sales | 3.58 | 5.33 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 1.02 | 11.50 | -5.98 | 16.21 | 31.68 |
| Core EBITDA Growth(%) | 10.69 | 19.25 | 26.52 | 13.67 | 33.44 |
| EBIT Growth(%) | 9.18 | 19.79 | 29.25 | 17.99 | 37.91 |
| PAT Growth(%) | 8.61 | 19.28 | 30.17 | 20.37 | 40.05 |
| EPS Growth(%) | 8.61 | 19.28 | 30.16 | -99.22 | 40.05 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | - | - | - | 0.02 |
| Current Ratio(x) | 7.60 | 7.28 | 6.07 | 3.82 | 3.21 |
| Quick Ratio(x) | 6.80 | 6.55 | 4.87 | 2.80 | 2.66 |
| Interest Cover(x) | 328.21 | - | - | 237.24 | 46.32 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of KRONOX LAB SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KRONOX LAB SCIENCES | ₹633.1 Cr | -1.8% | 13.2% | 5.5% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹174,193.0 Cr | -14.3% | -3.7% | 60.8% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹154,921.0 Cr | -4.2% | -9.9% | 1.1% | Stock Analytics | |
| SRF | ₹72,742.6 Cr | -2.9% | -5.9% | -15.3% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹50,506.3 Cr | -1.7% | -3% | 31.5% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹37,161.4 Cr | -3.6% | -11.8% | -7.2% | Stock Analytics | |
KRONOX LAB SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KRONOX LAB SCIENCES | -1.8% |
13.2% |
5.5% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses
